Home > Boards > US Listed > Biotechs >

Verona Pharma (VRNA)

VRNA RSS Feed
Add VRNA Price Alert      Hide Sticky   Hide Intro
Moderator: ADVFN_bioking
Search This Board: 
Last Post: 12/5/2019 10:55:46 AM - Followers: 2 - Board type: Free - Posts Today: 0

(VRNA-DD)Market-cap $57 M --Cash $51 M --Shares Out 13.17 M --Great Pipeline -- Strong Insider & Institutional Ownership -- Phase 2b readout of the COPD trial is imminent (during this Q) ,positive results could push this extreme low float stock closer or even above $10 . Unsidocvered and brutally undepriced Stock with massive upside Potential here .GL

Market-Cap $57 M
Cash $51 M
Price $3.90

Shares Out 13.17 M


"We are very pleased that our four-week Phase 2b dose-ranging clinical trial with nebulized ensifentrine is progressing according to plan and that we have completed enrollment of over 400 symptomatic patients with moderate to severe COPD. We anticipate completing this study around the end of 2019."


Presentation (from late November)
https://investors.veronapharma.com/static-files/9ed398c4-3150-4c0e-8fe3-1efe276fbffb


Verona Pharma has compound with 'massive potential to impact lives of COPD and asthma patients'...02.12.2019

https://www.biotech-capital.com/companies/news/908274/verona-pharma-has-compound-with--massive-potential-to-impact-lives-of-copd-and-asthma-patients--908274.html


Insider Buying
https://www.lse.co.uk/DirectorsDeals.asp?shareprice=VRP&share=Verona-Pharma


Top Shareholders :

Vivo Capital, LLC ...1.5M
OrbiMed ...1.3M
New Enterprise ...1.2M
Abingworth ...901.9K
VenBio Partners LLC ...875.0K
Novo Holdings A/S ...740.7K
Andera Partners ...720.9K
Aisling Capital ...443.6K
Tekla Capital ...275.0K
Arctic Fund ...120.4K






VRNA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VRNA News: Report of Foreign Issuer (6-k) 11/29/2019 09:00:53 AM
VRNA News: Report of Foreign Issuer (6-k) 11/22/2019 09:00:03 AM
VRNA News: Report of Foreign Issuer (6-k) 11/22/2019 08:49:29 AM
VRNA News: Verona Pharma to Present at Jefferies 2019 London Healthcare Conference 11/13/2019 02:00:00 AM
VRNA News: Verona Pharma to Participate in Two Upcoming Institutional Investor Conferences in New York 11/11/2019 02:00:00 AM
PostSubject
#3   Phase 2b results imminent + extreme low float ADVFN_bioking 12/05/19 10:55:46 AM
#2   strong buy ADVFN_bioking 12/04/19 10:40:28 AM
#1   Loadup guys before the clinical results hit the ADVFN_bioking 12/03/19 12:47:12 PM
PostSubject